June 8, 2017August 24, 2022
Keytruda Improves Survival in Advanced Melanoma Patients Compared to Yervoy, Phase 3 Trial Shows
News
Patients with unresectable or metastatic melanoma who were treated with Keytruda (pembrolizumab) in a pivotal clinical trial showed superior and sustained time ... Read more
June 6, 2017
New Evidence Presented on Accuracy of DecisionDx-Melanoma Prognosis Test
News
Castle Biosciences presented three abstracts on the validity of using its 31-Gene Expression Profile (GEP) Test for melanoma prognosis at the ... Read more
June 1, 2017June 2, 2017
Biothera to Present Detailed Design of Combo Therapy Study for Melanoma, Breast Cancer
News
Biothera Pharmaceuticals will present the detailed study design of the IMPRIME-1 clinical trial at the upcoming 2017 ASCO Annual Meeting June 2-6 in ... Read more
May 30, 2017
Researchers Provide New Insights into Melanoma Immune Resistance
News
A new study presents detailed information into the processes used by cancer cells to evade and resist the immune response. Researchers studied ... Read more
May 25, 2017May 25, 2017
New Clinical Trial Underway for Treatment of Advanced Melanoma
News
A new clinical trial is underway assessing the addition of the first-in-class AXL kinase inhibitor, BGB324, to standard of care treatment for patients with ... Read more
May 23, 2017May 23, 2017
Skin Cancer Awareness Month Brings Sun Safety to Schools
News
Educating people of all ages, particularly children, about the dangers of sun exposure is urgent to preventing the increased prevalence ... Read more
May 18, 2017
First Patient Enrolled in ONCOS-102, Keytruda Combo Trial for Advanced Melanoma
News
The first patient has been enrolled in Targovax‘s pilot clinical trial for advanced or unresectable melanoma patients whose cancer progressed after treatment ... Read more
May 16, 2017
ImmunoPulse IL-12 and Keytruda Combo Therapy to be Tested in Phase 2 Trial
News
The combination of ImmunoPulse IL-12 and the anti-PD-1 therapy Keytruda (pembrolizumab) soon will be tested in a Phase 2 trial for treatment ... Read more
May 11, 2017
Binimetinib Improves Progression-free Survival of Certain Melanoma Patients in Phase 3 Trial
News
Adding the small molecule MEK inhibitor binimetinib to the BRAF inhibitor encorafenib was safe and significantly prolonged the time to disease progression ... Read more
May 9, 2017May 9, 2017
Melanoma Scientist Among 6 in NYC Awarded Prestigious Research Prize
News
The Pershing Square Sohn Cancer Research Alliance has announced the six winners of the fourth edition of the annual Pershing ... Read more
May 4, 2017
Castle’s Gene Test Shows Accuracy in Predicting Recurrence, Spread of Head and Neck Melanoma
News
Castle Biosciences’ DecisionDx-Melanoma test can be used to accurately predict cancer recurrence and metastasis in patients with head and neck melanoma, ... Read more
April 25, 2017
IMP321, Keytruda Combo Trial Receives OK to Open Last Patient Group
News
Prima Biomed, an Australian biotechnology company developing immunotherapies for cancer and autoimmune diseases, announced it has received approval for the ... Read more

April 20, 2015April 20, 2015

Study Shows Advertising Influences Tanning Behavior

Melanoma, News

Advertising and magazines that present tanning on a beach as a paradise in exotic vacation destinations with smiling, tanned models may be influencing people to search out ways of getting more tanned, ... Read more

April 17, 2015April 18, 2015

Researchers Discover a Protein That Can Improve Malignant Melanoma Diagnosis and Possibly Treatment

Melanoma, News

Researchers at the University of Aarhus and the Aarhus University Hospital in Denmark discovered a specific protein associated with malignant melanomas that could be used as a marker for earlier diagnosis and potentially ... Read more

April 16, 2015April 16, 2015

Study Reports Fewer New Cases of Pediatric Melanoma

Melanoma, News

Findings from a new study published in The Journal of Pediatrics revealed that the rate of new pediatric melanoma cases decreased between 2004 and 2010 in the United States. A research team from ... Read more

April 15, 2015April 15, 2015

UV Tanning Revealed To Significantly Increase Skin Cancer Risk

News, Skin Cancer

“A Call to Action to Prevent Skin Cancer” by acting Surgeon General Dr. Boris Lushniak recently pointed out that the use of UV tanning beds are “strongly associated with increased skin cancer ... Read more

April 14, 2015April 14, 2015

Melanoma Epigenetic Regulators Underlie Melanoma Progression and Therapy-Resistance

News

In a new study entitled “Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state,” a research team at University of Leuven in Belgium reported two ... Read more

April 13, 2015April 14, 2015

Melanoma Metastatic Potential is Fuelled by CXCR3 Signaling

Melanoma, News

In a new study entitled “CXCR3 signaling in BRAFWT melanoma increases IL-8 expression and tumorigenicity,” researchers revealed that CXCR3 signaling promotes wild-type BRAF melanoma progression by inducing invasive and metastatic characteristics. The ... Read more

April 10, 2015April 10, 2015

Researchers Conduct First Systematic Study to Evaluate Anti-Cancer Nanoparticles Safety

Melanoma, News

An international multidisciplinary team published a study in the journal Nano Research establishing the safety of specific nanoparticles for cancer therapies using human skin cells. The study is entitled “Cytotoxicity ... Read more

April 8, 2015April 8, 2015

Promising Outcomes Reported For a Personalized Vaccine Against Cutaneous Melanoma

Melanoma, News

A new study is utilizing personalized immunotherapy to target specific tumor-associated genomic changes in an effort to combat tumors formed during cutaneous melanoma. The dendritic cell vaccine is tailored to ... Read more

April 8, 2015April 10, 2015

Immune Checkpoint Therapy Has A Promising Impact On Advanced Melanoma Treatment

Melanoma, News

Over the last four years, a promising new class of cancer therapeutics has emerged in which an innovative method, coined immune checkpoint therapy, is exploited to seek and destroy tumors ... Read more

April 7, 2015April 7, 2015

Pensioners in the UK More Likely To Be Diagnosed With Malignant Melanoma

News

According to Cancer Research UK, people aged over 65 years are about 7 times more likely to develop melanoma when compared to the same demographic group 40 years ago. Specifically researchers determined that ... Read more

April 6, 2015April 6, 2015

BRAF Gene Mutation Associated With Different Melanoma Subtypes

Melanoma, News

A recent study published in the journal Melanoma Research and led by researchers at the National Cancer Center Hospital in Tokyo, Japan revealed an association between mutations in the BRAF ... Read more

April 1, 2015April 1, 2015

New Therapeutic Molecule Tested on Melanoma Stops Cancer Development by Interfering with Cellular Communication Pathways

Melanoma, News

A study recently published in the journal Nature Communications revealed a new potential therapeutic molecule that can halt the delivery of biological information to melanoma cells without affecting healthy cells. The ... Read more

Keytruda Improves Survival in Advanced Melanoma Patients Compared to Yervoy, Phase 3 Trial Shows

New Evidence Presented on Accuracy of DecisionDx-Melanoma Prognosis Test

Biothera to Present Detailed Design of Combo Therapy Study for Melanoma, Breast Cancer

Researchers Provide New Insights into Melanoma Immune Resistance

New Clinical Trial Underway for Treatment of Advanced Melanoma

Skin Cancer Awareness Month Brings Sun Safety to Schools

First Patient Enrolled in ONCOS-102, Keytruda Combo Trial for Advanced Melanoma

ImmunoPulse IL-12 and Keytruda Combo Therapy to be Tested in Phase 2 Trial

Binimetinib Improves Progression-free Survival of Certain Melanoma Patients in Phase 3 Trial

Melanoma Scientist Among 6 in NYC Awarded Prestigious Research Prize

Castle’s Gene Test Shows Accuracy in Predicting Recurrence, Spread of Head and Neck Melanoma

IMP321, Keytruda Combo Trial Receives OK to Open Last Patient Group